Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

HLA-DRB1 typing by micro-bead array assay identifies the origin of early lymphoproliferative disorder in a heart transplant recipient.

Fedrigo M, Poli F, Esposito G, Feltrin G, Toscano G, d'Agostino C, Schiavon B, Gerosa G, Amadori A, Valente M, Thiene G, Angelini A.

Am J Transplant. 2013 Mar;13(3):802-7. doi: 10.1111/ajt.12063. Epub 2013 Jan 17.

2.

An unusual presentation of post-transplant lymphoproliferative disorder mimicking vasculitis in heart transplantation.

Murray DL, Pereira NL, Miller DV.

J Heart Lung Transplant. 2008 Nov;27(11):1257-61. doi: 10.1016/j.healun.2008.07.029.

PMID:
18971100
3.

Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.

Calabrese F, Loy M, Lunardi F, Marino D, Aversa SM, Rea F.

Transpl Infect Dis. 2010 Aug 1;12(4):342-6. doi: 10.1111/j.1399-3062.2009.00487.x. Epub 2009 Dec 20.

PMID:
20030794
4.

Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.

Abu-Farsakh H, Cagle PT, Buffone GJ, Bruner JM, Weilbaecher D, Greenberg SD.

Arch Pathol Lab Med. 1992 Jan;116(1):93-5.

PMID:
1310382
5.

In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.

Montone KT, Friedman H, Hodinka RL, Hicks DG, Kant JA, Tomaszewski JE.

Mod Pathol. 1992 May;5(3):292-302.

PMID:
1323104
6.

Post-transplant Lymphoproliferative Disorders: A Rare Case of Primary Pericardial Involvement Epstein-Barr Virus-Correlated in Heart Transplantation.

Toscano G, Fabozzo A, Fedrigo M, Gambino A, Angelini A, Gerosa G.

Transplant Proc. 2015 Sep;47(7):2287-90. doi: 10.1016/j.transproceed.2015.04.085.

PMID:
26361701
7.

Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.

Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.

J Heart Lung Transplant. 2008 Jan;27(1):100-5. doi: 10.1016/j.healun.2007.09.027.

PMID:
18187094
8.

Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection.

Drachenberg CB, Abruzzo LV, Klassen DK, Bartlett ST, Johnson LB, Kuo PC, Kumar D, Papadimitriou JC.

Hum Pathol. 1998 Jun;29(6):569-77.

PMID:
9635676
9.

Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.

Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA.

Hum Pathol. 1997 May;28(5):533-9.

PMID:
9158700
10.

Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.

Gulley ML, Swinnen LJ, Plaisance KT Jr, Schnell C, Grogan TM, Schneider BG; Southwest Oncology Group.

Transplantation. 2003 Sep 27;76(6):959-64.

PMID:
14508361
11.

A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients.

Chinnock R, Webber SA, Dipchand AI, Brown RN, George JF; Pediatric Heart Transplant Study.

Am J Transplant. 2012 Nov;12(11):3061-8. doi: 10.1111/j.1600-6143.2012.04197.x. Epub 2012 Oct 16.

12.

Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.

Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J Jr, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.

J Heart Lung Transplant. 1998 Dec;17(12):1161-6.

PMID:
9883755
13.

Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.

Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE.

Transplantation. 1999 Dec 27;68(12):1851-4.

15.
16.

Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation.

Petit B, Le Meur Y, Jaccard A, Paraf F, Robert CL, Bordessoule D, Labrousse F, Drouet M.

Transplantation. 2002 Jan 27;73(2):265-71.

PMID:
11821742
17.

Isolated pleural PTLD after cardiac transplantation.

Lamba M, Jabi M, Padmore R, Sengar DP, Veinot JP.

Cardiovasc Pathol. 2002 Nov-Dec;11(6):346-50.

PMID:
12459436
18.

Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease.

Wong JY, Tait B, Levvey B, Griffiths A, Esmore DS, Snell GI, Williams TJ, Kotsimbos TC.

Transplantation. 2004 Jul 27;78(2):205-10.

PMID:
15280679
19.

The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.

Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.

J Pediatr Gastroenterol Nutr. 2001 Oct;33(4):445-9.

PMID:
11698761
20.

Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.

Wasson S, Zafar MN, Best J, Reddy HK.

J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):77-83.

PMID:
16703222
Items per page

Supplemental Content

Write to the Help Desk